Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto; Massimiliano Fabbiani; Eugenia Quiros Roldan; Alessandra Latini; Gabriella D'Ettorre; Andrea Antinori; Antonella Castagna; Giancarlo Orofino; Daniela Francisci; Pierangelo Chinello; Giordano Madeddu; Pierfrancesco Grima; Stefano Rusconi; Massimo Di Pietro; Annalisa Mondi; Nicoletta Ciccarelli; Alberto Borghetti; Emanuele Focà; Manuela Colafigli; Andrea De Luca; Roberto Cauda

doi:10.1093/jac/dkw557

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto
, Massimiliano Fabbiani
, Eugenia Quiros Roldan
, Alessandra Latini
, Gabriella D'Ettorre
, Andrea Antinori
, Antonella Castagna
, Giancarlo Orofino
, Daniela Francisci
, Pierangelo Chinello
, Giordano Madeddu
, Pierfrancesco Grima
, Stefano Rusconi
, Massimo Di Pietro
, Annalisa Mondi
, Nicoletta Ciccarelli
, Alberto Borghetti
, Emanuele Focà
, Manuela Colafigli
, Andrea De Luca

Roberto Cauda

Risultato della ricerca: Contributo in rivista › Articolo

63 Citazioni (Scopus)

Abstract

not available

Lingua originale	Inglese
pagine (da-a)	dkw557-N/A
Rivista	Journal of Antimicrobial Chemotherapy
Numero di pubblicazione	n/a
DOI	https://doi.org/10.1093/jac/dkw557
Stato di pubblicazione	Pubblicato - 2017

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Farmacologia
Microbiologia (medica)
Farmacologia (medica)
Malattie Infettive

Keywords

dual therapy

Accesso al documento

10.1093/jac/dkw557

Altri file e collegamenti

Fingerprint

Entra nei temi di ricerca di 'Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)'. Insieme formano una fingerprint unica.

Cita questo

Di Giambenedetto, S., Fabbiani, M., Quiros Roldan, E., Latini, A., D'Ettorre, G., Antinori, A., Castagna, A., Orofino, G., Francisci, D., Chinello, P., Madeddu, G., Grima, P., Rusconi, S., Di Pietro, M., Mondi, A., Ciccarelli, N., Borghetti, A., Focà, E., Colafigli, M., ... Cauda, R. (2017). Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). Journal of Antimicrobial Chemotherapy, (n/a), dkw557-N/A. https://doi.org/10.1093/jac/dkw557

Di Giambenedetto, Simona ; Fabbiani, Massimiliano ; Quiros Roldan, Eugenia et al. / Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). In: Journal of Antimicrobial Chemotherapy. 2017 ; N. n/a. pagg. dkw557-N/A.

@article{65e07d8d2ffc4333b2ceb1e04b1efabe,

title = "Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)",

abstract = "not available",

keywords = "dual therapy, dual therapy",

author = "\{Di Giambenedetto\}, Simona and Massimiliano Fabbiani and \{Quiros Roldan\}, Eugenia and Alessandra Latini and Gabriella D'Ettorre and Andrea Antinori and Antonella Castagna and Giancarlo Orofino and Daniela Francisci and Pierangelo Chinello and Giordano Madeddu and Pierfrancesco Grima and Stefano Rusconi and \{Di Pietro\}, Massimo and Annalisa Mondi and Nicoletta Ciccarelli and Alberto Borghetti and Emanuele Foc{\`a} and Manuela Colafigli and \{De Luca\}, Andrea and Roberto Cauda",

year = "2017",

doi = "10.1093/jac/dkw557",

language = "English",

pages = "dkw557--N/A",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "n/a",

}

Di Giambenedetto, S, Fabbiani, M, Quiros Roldan, E, Latini, A, D'Ettorre, G, Antinori, A, Castagna, A, Orofino, G, Francisci, D, Chinello, P, Madeddu, G, Grima, P, Rusconi, S, Di Pietro, M, Mondi, A, Ciccarelli, N, Borghetti, A, Focà, E, Colafigli, M, De Luca, A & Cauda, R 2017, 'Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)', Journal of Antimicrobial Chemotherapy, n. n/a, pagg. dkw557-N/A. https://doi.org/10.1093/jac/dkw557

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). / Di Giambenedetto, Simona; Fabbiani, Massimiliano; Quiros Roldan, Eugenia et al.
In: Journal of Antimicrobial Chemotherapy, N. n/a, 2017, pag. dkw557-N/A.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

AU - Di Giambenedetto, Simona

AU - Fabbiani, Massimiliano

AU - Quiros Roldan, Eugenia

AU - Latini, Alessandra

AU - D'Ettorre, Gabriella

AU - Antinori, Andrea

AU - Castagna, Antonella

AU - Orofino, Giancarlo

AU - Francisci, Daniela

AU - Chinello, Pierangelo

AU - Madeddu, Giordano

AU - Grima, Pierfrancesco

AU - Rusconi, Stefano

AU - Di Pietro, Massimo

AU - Mondi, Annalisa

AU - Ciccarelli, Nicoletta

AU - Borghetti, Alberto

AU - Focà, Emanuele

AU - Colafigli, Manuela

AU - De Luca, Andrea

AU - Cauda, Roberto

PY - 2017

Y1 - 2017

N2 - not available

AB - not available

KW - dual therapy

UR - https://publicatt.unicatt.it/handle/10807/94864

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85018232412&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85018232412&origin=inward

U2 - 10.1093/jac/dkw557

DO - 10.1093/jac/dkw557

M3 - Article

SN - 0305-7453

SP - dkw557-N/A

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - n/a

ER -

Di Giambenedetto S, Fabbiani M, Quiros Roldan E, Latini A, D'Ettorre G, Antinori A et al. Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). Journal of Antimicrobial Chemotherapy. 2017;(n/a):dkw557-N/A. doi: 10.1093/jac/dkw557